.png)
.png)
.png)
.png)
.png)
.png)
Clinical case 01
When standard labs miss disease
Discordant lipid-risk signals in an asymptomatic adult
Abstract
A 46-year-old man seeking health optimization had younger biological-age estimates alongside adverse lipid-related epigenetic proxies. Subsequent conventional investigations documented dyslipidemia and coronary plaque. This summary separates screening signals from confirmatory findings.
Patient information
The patient was fit and asymptomatic, with strength and sprint training, a high-protein diet, and a high-stress job. Routine laboratory findings were described as reassuring; numerical results and physical examination findings were not provided.
Reported aging measures
Age differences are relative to chronological age. DunedinPACE is a pace measure, not an age in years.
Reported proxies included low PON1 and ApoA1, elevated ApoB, and small dense LDL. These were methylation-derived signals, not direct serum concentrations.
Clinical course
Sequence reported in the source; dates were not provided.
- 01 · Initial assessmentHealth optimization visit; reassuring routine laboratory findings described.
- 02 · Further investigationFasting lipids confirmed dyslipidemia. Coronary CT angiography showed mixed calcified and noncalcified plaque.
- 03 · ManagementA statin was started and diet reviewed. A PCSK9 inhibitor was discussed; initiation was not reported.
- 04 · Follow-upMedication dose, treatment duration, repeat results, and clinical outcomes were not reported.
Discussion and limitations
The younger age estimates did not exclude pathway-specific risk. The clinical findings depended on conventional lipid testing and imaging. A single case cannot establish the diagnostic accuracy of methylation proxies or show that testing improves outcomes.
Clinical takeaway
Interpret aging measures and epigenetic proxies in the context of the patient’s history, examination, and conventional diagnostic testing.